Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: Our experience with a prospective study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

254

HTML

1755

Figures (1-4)

119

Tables (1-2)

100

Sum=2228

Apr 14, 2006 (publication date) through Apr 16, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Apr 14, 2006; 12(14): 2201-2204
Published online Apr 14, 2006. doi: 10.3748/wjg.v12.i14.2201

Figure 1 Evolution of CAI (A) and EI (B) in UC patients.

Figure 2 Mean evolution of CRP (A) and ESR (B) in UC patients.

Figure 3 Mean evolution of CDAI (A), CRP (B) and ESR (C) in CD patients.

Figure 4 Remission during follow-up.

Citation: Giampaolo B, Giuseppe P, Michele B, Alessandro M, Fabrizio S, Alfonso C. Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: Our experience with a prospective study. World J Gastroenterol 2006; 12(14): 2201-2204
URL: https://www.wjgnet.com/1007-9327/full/v12/i14/2201.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i14.2201